Clinical Trial Update: K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability [Phase 1]

View source ↗

Summary

Phase 1 study of K-001 as monotherapy in advanced pancreatic cancer completed. The trial focused on tolerability and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• K-001

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED